Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) Dutch Colorectal Cancer Group the TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246: 693–701PubMedCrossRef

Valentini V, Aristei C, Glimelius B et al (2009) Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 92: 148–163PubMedCrossRef

Fazio VW, Zutshi M, Remzi FH et al (2007) A randomized multicentric trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg 246: 481–488PubMedCrossRef

den Dulk M, Putter H, Collette L et al (2009) The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 45: 1175–1183CrossRef

Stelzner S, Koehler C, Stelzer J et al (2011) Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer-a systematic overview. Int J Colorectal Dis 26: 1227–1240PubMedCrossRef

van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12: 575–582PubMedCrossRef

Peng J, Chen W, Sheng W et al (2011) Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Dis 13: 14–19CrossRef

Moore JS, Cataldo PA, Osier T et al (2008) Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon Rectum 51: 1026–1030PubMedCrossRef

Hahnloser D, Wolff BG, Larson DW et al (2005) Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum 48: 429–437PubMedCrossRef

Piessen G, Gabral C, Benoist S et al (2012) Previous transanal full-thickness excision increases the morbidity of radical resection for rectal cancer. Colorectal Dis 14: 445–452PubMedCrossRef

Doornebosh PG, Ferenschild FT, de Wilt JH et al (2010) Treatment of recurrence after transanal endoscopic microsurgery (TEM) for T1 rectal cancer. Dis Colon Rectum 53: 1234–1239CrossRef

Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373: 811–820PubMedCrossRef

Roedel C, Becker H, Fietkau R et al (2011) Preoperative chemoradiotherapy and postoperative chemotherapy with 5-fluorouracil and oxaliplatin versus 5-fluorouracil alone in locally advanced rectal cancer: First results of the German CAO/ARO/AIO-04 randomized phase III trial. J Clin Oncol 29(suppl):abs 3505

Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93: 1215–1223PubMedCrossRef

MERCURY study group (2007) Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 243: 132–139CrossRef

Peeters KC, van den Velde CJ, Leer JW et al (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients-a Dutch colorectal cancer group study. J Clin Oncol 23: 6199–6206PubMedCrossRef

Schmoll HJ, Van Cutsem E, Stein A et al (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 23: 2479–2516PubMedCrossRef